A carregar...
Mesothelin expression is associated with poor outcomes in breast cancer
BACKGROUND: Mesothelin, previously shown to be expressed in triple negative breast cancer (TNBC), is a potential therapeutic target and prognostic marker in breast cancer. METHODS: We analyzed clinical data from two cohorts comprising of 141 patients treated between 2009 and 2011 at our institution...
Na minha lista:
| Publicado no: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261925/ https://ncbi.nlm.nih.gov/pubmed/25193277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3077-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|